There have been 50 recent insider transactions recorded for Mineralys Therapeutics, Inc. (MLYS), including 21 buys and 28 sells. Total insider buying was valued at $61.26M and total insider selling at $2.63M.
Notable insiders with recent activity include Congleton Jon, Karydas Daphne, Ra Capital Management, L.p.. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — MLYS
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-31 |
Congleton Jon |
Chief Executive Officer |
Informative Sell |
453 |
$27.05 |
$12.25K |
705,051 |
| 2026-03-31 |
Karydas Daphne |
Director |
Informative Sell |
3,000 |
$25.00 |
$75K |
6,200 |
| 2026-03-30 |
Ra Capital Management, L.p. |
Director |
Informative Buy |
58,300 |
$24.16 |
$1.41M |
5,825,521 |
| 2026-03-27 |
Ra Capital Management, L.p. |
Director |
Informative Buy |
310,700 |
$23.67 |
$7.35M |
5,767,221 |
| 2026-03-17 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
417 |
$15.44 |
$6.44K |
5,000 |
| 2026-03-13 |
Rodman David Malcom |
Chief Medical Officer |
Informative Sell |
253 |
$27.82 |
$7.04K |
76,140 |
| 2026-03-12 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
6,348 |
$1.08 |
$6.86K |
25,395 |
| 2026-03-09 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
2,171 |
$16.00 |
$34.74K |
23,876 |
| 2026-03-04 |
Warren Eric |
Chief Commercial Officer |
Unknown |
357,000 |
$13.24 |
$4.73M |
- |
| 2026-02-19 |
Akkaraju Srinivas |
10 Percent Owner |
RSU Award |
6,200 |
- |
- |
6,200 |
| 2026-02-19 |
Sblendorio Glenn |
Director |
RSU Award |
6,200 |
- |
- |
6,200 |
| 2026-02-19 |
Ra Capital Management, L.p. |
Director |
RSU Award |
6,200 |
- |
- |
6,200 |
| 2026-02-19 |
Congleton Jon |
Chief Executive Officer |
RSU Award |
187,900 |
$28.06 |
$5.27M |
187,900 |
| 2026-02-19 |
Rodman David Malcom |
Chief Medical Officer |
RSU Award |
51,300 |
$28.06 |
$1.44M |
51,300 |
| 2026-02-19 |
Levy Adam Scott |
CFO and Secretary |
RSU Award |
39,900 |
- |
- |
48,538 |
| 2026-02-19 |
Dirocco Derek |
Director |
RSU Award |
6,200 |
- |
- |
6,200 |
| 2026-02-19 |
Karydas Daphne |
Director |
RSU Award |
6,200 |
- |
- |
6,200 |
| 2026-02-19 |
Slingsby Brian Taylor |
10 Percent Owner |
Other (Sell) |
6,200 |
- |
- |
- |
| 2026-02-19 |
Gold Alexander M |
Director |
RSU Award |
6,200 |
- |
- |
6,200 |
| 2026-02-17 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
417 |
$15.44 |
$6.44K |
5,417 |
| 2026-02-13 |
Rodman David Malcom |
Chief Medical Officer |
Informative Sell |
6,348 |
$27.58 |
$175.1K |
44,089 |
| 2026-02-12 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
6,349 |
$1.08 |
$6.86K |
31,743 |
| 2026-02-09 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
2,171 |
$16.00 |
$34.74K |
26,047 |
| 2026-01-20 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
416 |
$15.44 |
$6.42K |
5,834 |
| 2026-01-14 |
Rodman David Malcom |
Chief Medical Officer |
Informative Sell |
11,367 |
$32.61 |
$370.64K |
50,437 |
| 2026-01-13 |
Rodman David Malcom |
Chief Medical Officer |
Informative Sell |
7,709 |
$32.75 |
$252.47K |
61,804 |
| 2026-01-12 |
Congleton Jon |
Chief Executive Officer |
Informative Sell |
7,117 |
$33.15 |
$235.93K |
639,151 |
| 2026-01-12 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
6,348 |
$1.08 |
$6.86K |
38,092 |
| 2026-01-12 |
Levy Adam Scott |
CFO and Secretary |
Informative Sell |
10,758 |
$32.14 |
$345.72K |
8,638 |
| 2026-01-09 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
2,170 |
$16.00 |
$34.72K |
28,218 |
| 2026-01-05 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise |
28,038 |
$1.08 |
$30.28K |
97,226 |
| 2026-01-02 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
20,168 |
$16.00 |
$322.69K |
84,018 |
| 2025-06-13 |
Rodman David Malcom |
Chief Medical Officer |
Informative Sell |
11,366 |
$14.60 |
$165.93K |
101,651 |
| 2025-06-12 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
6,348 |
$1.08 |
$6.86K |
95,229 |
| 2025-05-14 |
Rodman David Malcom |
Chief Medical Officer |
Informative Sell |
11,366 |
$15.29 |
$173.77K |
106,669 |
| 2025-05-12 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
6,349 |
$1.08 |
$6.86K |
101,577 |
| 2025-04-14 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
6,348 |
$1.08 |
$6.86K |
107,926 |
| 2025-04-11 |
Congleton Jon |
Chief Executive Officer |
Informative Sell |
15,319 |
$12.19 |
$186.8K |
862,289 |
| 2025-04-11 |
Levy Adam Scott |
CFO and Secretary |
Informative Sell |
10,757 |
$12.06 |
$129.68K |
215,340 |
| 2025-04-01 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
1,606 |
$1.08 |
$1.73K |
114,274 |
| 2025-03-13 |
Akkaraju Srinivas |
Director |
Informative Buy |
600,000 |
$13.50 |
$8.1M |
5,674,916 |
| 2025-03-13 |
Ra Capital Management, L.p. |
Director |
Informative Buy |
1,296,296 |
$13.50 |
$17.5M |
4,280,051 |
| 2025-03-13 |
Samsara Biocapital Gp, Llc |
10 Percent Owner |
Informative Buy |
600,000 |
$13.50 |
$8.1M |
5,674,916 |
| 2025-03-13 |
Slingsby Brian Taylor |
10 Percent Owner |
Informative Buy |
259,259 |
$13.50 |
$3.5M |
8,903,838 |
| 2025-03-12 |
Rodman David Malcom |
Chief Medical Officer |
Option Exercise (Sell) |
6,349 |
$1.08 |
$6.86K |
115,880 |
| 2025-02-13 |
Akkaraju Srinivas |
10 Percent Owner |
RSU Award |
32,900 |
$10.20 |
$335.58K |
32,900 |
| 2025-02-13 |
Sblendorio Glenn |
Director |
RSU Award |
32,900 |
$10.20 |
$335.58K |
32,900 |
| 2025-02-13 |
Ra Capital Management, L.p. |
Director |
RSU Award |
32,900 |
$10.20 |
$335.58K |
32,900 |
| 2025-02-13 |
Congleton Jon |
Chief Executive Officer |
RSU Award |
570,000 |
$10.20 |
$5.81M |
570,000 |
| 2025-02-13 |
Rodman David Malcom |
Chief Medical Officer |
RSU Award |
170,000 |
$10.20 |
$1.73M |
170,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
